Results 261 to 270 of about 187,246 (326)
Abstract Background Immune checkpoint inhibitors can be coadministered as a fixed‐ratio combination (FRC) or administered as sequential infusions (ASI). Two randomized, open‐label trials compared nivolumab + ipilimumab as a FRC versus ASI in patients with melanoma or renal cell carcinoma.
Alexander M. Menzies+19 more
wiley +1 more source
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma-overview. [PDF]
Ohmachi K.
europepmc +1 more source
MS275 Inhibits Neuroblastoma Cell Growth by Mediating H3K27ac/PROX1 Axis In Silico and In Vitro
Our study demonstrates that MS275, a selective HDAC inhibitor, suppresses HDAC1/3 protein expression, leading to hyperacetylation of histone H3 at lysine 27 (H3K27ac) within the PROX1 promoter region (−608 to −508). This epigenetic modification upregulates PROX1 transcription, which subsequently modulates key cellular processes, including cell cycle ...
Chao Yuan+11 more
wiley +1 more source
A mature T-cell neoplasm with features of peripheral T-cell lymphoma, not otherwise specified presenting with multiple cutaneous tumors on the scalp in a patient with long-standing lichen planopilaris. [PDF]
Jones BA+6 more
europepmc +1 more source
Modified total skin electron treatment for a paraplegic patient
Abstract Total Skin Electron Therapy (TSET) has been a highly effective treatment for mycosis fungoides (MF). However, the standard TSET treatment requires the patient to stand upright in six different positions for an extended time period, which may not be possible for some patients.
Thomas Martin+5 more
wiley +1 more source
Extensive Scaly Erythema with Recurring Ulcers and Crusts: A Quiz. [PDF]
Zhu D, Chen B, Zhou Y.
europepmc +1 more source
Commissioning and clinical implementation of low dose dual‐field rotational TSET
Abstract Background Total skin electron therapy (TSET) is a specialized technique for treating cutaneous T‐cell lymphomas, such as mycosis fungoides. While traditional TSET regimens prescribe 30–36 Gy, low dose TSET at 12 Gy has gained attention due to its reduced toxicity.
Broderick Ivan McCallum‐Hee+8 more
wiley +1 more source
Abstract Background Indoleamine 2,3‐dioxygenase 1 (IDO1) is a heme‐containing enzyme that degrades tryptophan (Trp) to kynurenine (Kyn), which suppresses effector T cells and reduces antitumor activity. KHK2455 is a long‐acting selective IDO1 inhibitor that blocks the heme component of the IDO holoenzyme.
Timothy A. Yap+16 more
wiley +1 more source
Canine lymphoma in Croatia: a fourteen-year retrospective study. [PDF]
Eraghi V+10 more
europepmc +1 more source
Sézary Syndrome—Eosinophilia Explained by a Blood Film
American Journal of Hematology, Volume 100, Issue 8, Page 1423-1424, August 2025.
Merel T. A. Soeterik+5 more
wiley +1 more source